Abstract:ders with weight reduction strategies to lower the cardiovascular risk. There is an increasing need for a more comprehensive approach and an intensified collaboration of primary care physicians and specialists of diabetology, cardiology, obesity, gastroenterology, and bariatric surgery. Because unhealthy body weight represents an important factor in the development of the metabolic syndrome, weight control as well as therapies aiming for a healthier body weight are the basic prevention and treatment tools in the management of patients with the metabolic syndrome. In the past, lifestyle interventions as well as pharmacological and endoscopic therapies have only provided limited and short-term success whereas visceral surgery currently remains the most effective therapy. Originally conceived in an attempt to merely reduce excessive weight and to improve cosmetic appearance, bariatric surgery has undergone an evolutionary development throughout the years, allowing it to be now recognized as a valued surgical treatment of obesity in conjunction with its correlated metabolic complications. Today, reversing metabolic complications of obesity has a higher priority than weight loss per se. The modern term ‘metabolic surgery’ is employed to indicate the use of gastrointestinal surgery to primarily and purposely treat metabolic disorders rather than to simply act on body weight reduction. The decision of choosing this particular focus topic is an invitation to physicians and surgeons in the field of visceral medicine to take up the challenges of treating patients with metabolic syndrome. Accordingly, we have invited acknowledged scientific teams from Germany, Austria, and Switzerland to elucidate the current understanding of the metabolic syndrome and to foresee future trends in their field. As a result, the current issue of Visceral Medicine is a multifaceted overview to foster interdisciplinary activities both at the laboratory bench and the bedside. The literature search for ‘metabolic syndrome and obesity’ reveals its first citation in PubMed in the year 1970 [1]. The first review in the German language was presented by Hanefeld and Leonhardt 11 years later and described the common prevalence of obesity, hyperand dyslipoproteinemia, maturity-onset diabetes, gout, and hypertension associated with an increased incidence of atherosclerotic vascular disease, fatty liver disease, and gallstones [2]. The rapid increase in the number of publications on the above topic from 56 in the year 2000 to more than 500 by the year 2013 represents the increased awareness and interest of researchers and clinicians alike. What used to be an adult-onset disease is now discovered in children and adolescents with alarming frequency. Hence, obesity and the metabolic syndrome have become one of the greatest public health challenges worldwide within the last decade. The concept of the metabolic syndrome represents a comprehensive view of a multidimensional network of risk factors and cardiovascular, metabolic, and hepatic diseases. The metabolic syndrome describes a risk factor clustering for cardiovascular disease and type 2 diabetes mellitus, which includes central obesity, elevated glucose and triglyceride plasma concentrations, low highdensity lipoprotein cholesterol levels, high blood pressure, and a proinflammatory, prothrombotic state. There is now compelling evidence that each component is not restricted to one singular organ but affects multiple organs in a multisystem disease fashion. Although insulin resistance and visceral obesity are central pathophysiological factors, the underlying common mechanism remains to be elusive. The research in order to identify the underlying mechanisms requires a much broader scientific effort in molecular biology, pathophysiology, epidemiology, and clinical research. Similarly, the current management of the metabolic syndrome combines an individualized therapy of manifest individual disorPublished online: October 21, 2016

Assortative Mating on Blood Type: Evidence from One Million Chinese Pregnancies

Polymorphism in Maternal HLA-DRB5 is Associated with the Risk of Preeclampsia in Chinese Population

Molecular Basis of ABO Variants Including Identification of 16 Novel ABO Subgroup Alleles in Chinese Han Population

Reproductive Strategy Inferred from Major Histocompatibility Complex-Based Inter-Individual, Sperm-Egg, and Mother-Fetus Recognitions in Giant Pandas (ailuropoda Melanoleuca)

Husband/Wife Joint AB Blood Group is Associated With Clinical Outcomes of IVF/ICSI Treatment in Chinese Women

Genetic analyses of 104 phenotypes in 20,900 Chinese pregnant women reveal pregnancy-specific discoveries

MHC-Dependent Mate Selection within 872 Spousal Pairs of European Ancestry from the Health and Retirement Study

Metabolic Syndrome: An Interdisciplinary Approach

The Genetic Analysis and Prediction of the Huamn Blood Type

Association between cellular immune and preeclampsia and preterm birth: a Mendelian randomization study

The influence of HLA allele and haplotype on RhE alloimmunization among pregnant females in the Chinese Han population

Hybrid Marriages and Phenotypic Heterosis in Offspring: Evidence from China.

Assortative Mating Without Assortative Preference

Assortative Mating on Ancestry-Variant Traits in Admixed Latin American Populations

Familial correlation and aggregation of body mass index and blood pressure in Chinese Han population

Hemoglobin concentrations in early pregnancy and their associations with adverse pregnancy outcomes in Western China: a population-based study

Frequencies and Ethnic Distribution of ABO and RhD Blood Groups in China: a Population-Based Cross-Sectional Study

The effect of histo-blood group ABO system transferase (BGAT) on pregnancy related outcomes：A Mendelian randomization study

The Dynamic Genetic Atlas of 122 Gestational Phenotypes

Genomic Analyses from Non-invasive Prenatal Testing Reveal

Maternal pre-pregnancy BMI, MTHFR polymorphisms, and the risk of adverse pregnancy outcomes in pregnant women from South China: a retrospective cohort study